Lysosomotropic agents as HCV entry inhibitors
Open Access
- 12 April 2011
- journal article
- Published by Springer Science and Business Media LLC in Virology Journal
- Vol. 8 (1), 163
- https://doi.org/10.1186/1743-422x-8-163
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Frequency distribution of hepatitis C virus genotypes in different geographical regions of Pakistan and their possible routes of transmissionBMC Infectious Diseases, 2008
- Different pH requirements are associated with divergent inhibitory effects of chloroquine on human and avian influenza A virusesVirology Journal, 2007
- Hydroxychloroquine, hydroxyurea and didanosine as initial therapy for HIV‐infected patients with low viral load: safety, efficacy and resistance profile after 144 weeksHIV Medicine, 2005
- Infectious Hepatitis C Virus Pseudo-particles Containing Functional E1–E2 Envelope Protein ComplexesThe Journal of Experimental Medicine, 2003
- Ribavirin and interferon alfa‐2b in chronic hepatitis C: assessment of possible pharmacokinetic and pharmacodynamic interactionsBritish Journal of Clinical Pharmacology, 1998
- Inhibition of Human Immunodeficiency Virus Infectivity by ChloroquineAIDS Research and Human Retroviruses, 1990
- Chloroquine and ammonium chloride prevent terminal glycosylation of immunoglobulins in plasma cells without affecting secretionNature, 1986
- Weakly basic amines inhibit the proteolytic conversion of proalbumin to serum albumin in cultured rat hepatocytesJBIC Journal of Biological Inorganic Chemistry, 1985
- Inhibition of Vesicular Stomatitis Virus Glycoprotein Expression by ChloroquineJournal of General Virology, 1982
- Effect of weak bases on the intralysosomal pH in mouse peritoneal macrophages.The Journal of cell biology, 1981